DiGeorge/VCFS N25 and 22q13.3 Deletion Syndrome Combination Probe

FMDC-14

DiGeorge syndrome, and a variety of congenital malformation syndromes including Velocardiofacial (VCFS) and Conotruncal Anomaly Face syndromes, share the phenotypic features covered by the acronym CATCH22 (Cardiac defects; Abnormal facies; Thymic hypoplasia; Cleft palate; Hypocalcaemia) and deletion of chromosome 22 at 22q11.2. This probe is a 117 kb red probe that hybridizes to the 22q11 region of chromosome 22. The hybridization target spans from 87 kb centromeric to the HIRA gene to a point within the gene, 13 kb from from its telomeric end. 22q is 96 kb in size, labeled in SpectrumGreen and hybridizes to the 22q13 subtelomeric region of chromosome 22.

5 Tests, 10 Tests. 20 Tests

Red/Green

Human

22q11/22q13

For Research Use Only. Not for use in diagnostic procedures.

Store at minus 20 centigrade

If you use this products in your scientific publication, it should be cited in the publication as: Creative Bioarray cat no. If your paper has been published, please click here to submit the PubMed ID of your paper to get a coupon.